Öz
Amaç
Çalışmanın amacı, psikiyatri hastalarında bilişsel içgörü ile tedaviye uyum arasındaki ilişkiyi incelemektir.
Yöntem
Tanımlayıcı, kesitsel ve ilişki arayıcı tasarıma sahip bu çalışma, Şubat-Nisan 2023 tarihleri arasında İstanbul’daki bir kamu hastanesindeki 140 psikiyatri hastası ile gerçekleştirilmiştir. Veriler, kişisel bilgi formu, Morisky ilaç uyumu ölçeği ve Beck bilişsel içgörü ölçeği kullanılarak toplanmıştır. İstatistiksel analizlerde SPSS 25.0 ve AMOS 24.0 programları aracılığıyla doğrulayıcı faktör analizi ve yapısal eşitlik modellemesi uygulanmıştır.
Bulgular
Bilişsel içgörünün kendini ifade etme alt boyutu, tedavi uyumu üzerinde istatistiksel olarak anlamlı ve pozitif bir etkiye sahiptir (β=0,259; p<0,001). Bu durum, ifade yetisi yüksek olan hastaların daha yüksek düzeyde tedavi uyumu gösterdiğini ortaya koymaktadır. Buna karşılık, kendine güven alt boyutunun tedavi uyumu üzerinde anlamlı bir etkisi bulunmamıştır (β=0,050; p>0,05). Kurulan model, tedavi uyumundaki varyansın %10,5’ini açıklamaktadır.
Sonuç
Bilişsel içgörünün önemli bir alt boyutu olan kendini ifade etme yetisi, psikiyatri hastalarında tedavi uyumunun anlamlı bir yordayıcısıdır. Bu yetinin güçlendirilmesi, terapötik katılımı ve tedaviye uyumu artırabilir. Ancak, klinik bağlamda yalnızca kendine güvenin doğrudan bir etkisi gözlenmemiştir. Bu bulgular, psikiyatrik bakım süreçlerine içgörü odaklı müdahalelerin dahil edilmesinin önemini vurgulamaktadır.
Anahtar Kelimeler: Bilişsel içgörü, kendine güven, öz yansıtma, psikiyatri hastaları, tedavi uyumu
Kaynakça
Borba LO, Capistrano FC, Ferreira ACZ, Kalinke LP, Mantovani MF, Maftum MA. Adaptation and validation of the measuring of treatment adherence for mental health. Rev Bras Enferm. 2018;71(Suppl 5):2243-2250. English, Portuguese.
Mukattash TL, Alzoubi KH, Abu El-Rub E, Jarab AS, Al-Azzam SI, Khdour M, et al. Prevalence of non-adherence among psychiatric patients in Jordan, a cross sectional study. Int J Pharm Pract. 2016;24(3):217-221.
World Health Organization. World mental health report: transforming mental health for all [Internet]. Geneva: World Health Organization; 2022 [cited 2025 Sep 3]. Available from: https://www.who.int/publications/i/item/9789240049338?utm_source=chatgpt.com
Jayasree A, Shanmuganathan P, Ramamurthy P, Alwar Mc. Types of medication non-adherence & approaches to enhance medication adherence in mental health disorders: a narrative review. Indian J Psychol Med. 2024;46(6):503-510.
Alene M, Wiese MD, Angamo MT, Bajorek BV, Yesuf EA, Wabe NT. Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population. BMC Clin Pharmacol. 2012;12:10.
De Las Cuevas C, de Leon J, Peñate W, Betancort M. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach. Patient Prefer Adherence. 2017;11:681-690.
Van Dorn RA, Desmarais SL, Petrila J, Haynes D, Singh JP. Effects of outpatient treatment on risk of arrest of adults with serious mental illness and associated costs. Psychiatr Serv. 2013;64(9):856-862.
Timlin U, Hakko H, Heino R, Kyngäs H. A systematic narrative review of the literature: adherence to pharmacological and nonpharmacological treatments among adolescents with mental disorders. J Clin Nurs. 2014;23(23-24):3321-3334.
Klinpiboon P, Chanthapasa K. The medication use issues and challenges of mental illness exacerbation in patients with schizophrenia: a qualitative study in thailand. Patient Prefer Adherence. 2023;17:2927-2937.
Lee E, Jang MH. The influence of body image, insight, and mental health confidence on medication adherence in young adult women with mental disorders. Int J Environ Res Public Health. 2021;18(8):3866.
Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. BMC Psychiatry. 2015;15:189.
Özdel K, Kart A, Türkçapar MH. Cognitive behavioral therapy in treatment of bipolar disorder. Noro Psikiyatr Ars. 2021;58(Suppl 1):S66-S76.
Dalseth N, Reed RS, Hennessy M, Eisenberg MM, Blank MB. Does diagnosis make a difference? Estimating the impact of an HIV medication adherence intervention for persons with serious mental illness. AIDS Behav. 2018;22(1):265-275.
Van Camp LSC, Sabbe BGC, Oldenburg JFE. Cognitive insight: a systematic review. Clin Psychol Rev. 2017;55:12-24.
Hussein F, Shafik H, Eweida RS. Metacognitive abilities within personal narratives of inpatients with schizophrenia: associations with clinical insight and drug compliance. J Educ Pract. 2019;10(1):108-117.
Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200-218.
López-Carrilero R, Lo Monaco M, Frígola-Capell E, Ferrer-Quintero M, Díaz-Cutraro L, Verdaguer-Rodríguez M, et al; Spanish Metacognition Group; Ochoa S. Cognitive insight in first-episode psychosis: exploring the complex relationship between executive functions and social cognition. Span J Psychiatry Ment Health. 2024;17(3):160-167.
Ciufolini S, Morgan C, Morgan K, Fearon P, Boydell J, Hutchinson G, et al. Self esteem and self agency in first episode psychosis: ethnic variation and relationship with clinical presentation. Psychiatry Res. 2015;227(2-3):213-218.
Kao YC, Liu YP. The clinical applicability of the self-appraisal of illness questionnaire (SAIQ) to chronic schizophrenic patients in Taiwan. Psychiatr Q. 2010;81(3):215-25.
El Abdellati K, De Picker L, Morrens M. Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis. Front Neurosci. 2020;14:531763.
Bora E, Özerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med. 2017;47(16):2753-2766.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
Bahar G, Savaş HA, Ünal A, Savaş E, Kaya H, Bahar A. Validity and reliability study of the morisky medication adherence scale for bipolar disorder. Anatol J Psychiatry. 2014;15(2):141-149.
Beck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the beck cognitive insight scale. Schizophr Res. 2004;68(2-3):319-329.
Aslan S, Yavuz MF, Kaya N. Beck cognitive insight scale: a study of validity and reliability. Arch Neuropsychiatry. 2014;51(1):6-11.
Sharkiya SH. Quality communication can improve patient-centred health outcomes among older patients: a rapid review. BMC Health Serv Res. 2023;23(1):886.
Fereidooni S, Razeghian Jahromi L, Fateh N. Effectiveness of group cognitive behavioral therapy in insight and treatment adherence in schizophrenic patients: a randomized controlled trial. Jundishapur J Chronic Dis Care. 2023;12(3):e135541.
Hong H, Oh HJ. The effects of patient-centered communication: exploring the mediating role of trust in healthcare providers. Health Commun. 2020;35(4):502-511.
Koç M, Günaydın N. The relationship between treatment adherence, social support and recovery status of patients receiving psychiatric treatment. Online Turk J Health Sci. 2023;8(3):288-295.
Aylaz R, Kılınç G. The relationship between treatment adherence and social support in psychiatric patients in the east of Turkey. Arch Psychiatr Nurs. 2017;31(2):157-163.
Kokurcan A, Karadağ H, Ercan Doğu S, Erdi F, Örsel S. Clinical correlates of treatment adherence and insight in patients with schizophrenia. Arch Clin Exp Med. 2020;5(3):95-99.
Staring AB, Van der Gaag M, Koopmans GT, Selten JP, Van Beveren JM, Hengeveld MW, et al. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry. 2010;197(6):448-455.
Sagayadevan V, Jeyagurunathan A, Lau YW, Shafie S, Chang S, Ong HL, et al. Cognitive insight and quality of life among psychiatric outpatients. BMC Psychiatry. 2019;19(1):201.
Cooke MA, Peters ER, Fannon D, Aasen I, Kuipers E, Kumari V. Cognitive insight in psychosis: the relationship between self-certainty and self-reflection dimensions and neuropsychological measures. Psychiatry Res. 2010;178(2):284-289.
Kimhy D, Vakhrusheva J, Jobson-Ahmed L, Tarrier N, Malaspina D, Gross JJ. Emotion awareness and regulation in individuals with schizophrenia: implications for social functioning. Psychiatry Res. 2012;200(2-3):193-201.
Lysaker PH, Vohs J, Hasson-Ohayon I, Kukla M, Wierwille J, Dimaggio G. Depression and insight in schizophrenia: comparisons of levels of deficits in social cognition and metacognition and internalized stigma across three profiles. Schizophr Res. 2013;148(1-3):18-23.
Liu J, Chan TCT, Chong SA, Subramaniam M, Mahendran R. Impact of emotion dysregulation and cognitive insight on psychotic and depressive symptoms during the early course of schizophrenia spectrum disorders. Early Interv Psychiatry. 2020;14(6):691-697.
Tiryaki A, Karahan M. The relationship between insight and symptoms in Turkish schizophrenia outpatients. Turk J Psychiatry. 2018;29(1):19-27.
